NCT00060996View on ClinicalTrials.gov

Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures

PHASE3TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Critical Limb IschemiaPeripheral Vascular DiseaseFoot UlcersRest Leg Pain
Interventions
DRUG

Remodulin® (treprostinil sodium) Injection

Trial Locations (7)

19104

Presbyterian Medical Center, Philadelphia Heart Institute, Philadelphia

29204

South Carolina Heart Center, Columbia

33606

University of South Florida College of Medicine, Tampa

77030

The Methodist Hospital, Houston

97239

Oregon Health Sciences University, Portland

01655

University of Massachusetts Memorial Health, Worcester

55407-1139

Minneapolis Heart Institute, Minneapolis

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY